Next month in San Jose, CA, the AVS 56th International Symposium and Exhibition will showcase a spectrum of science and engineering research that is leading to breakthroughs in nanotechnology, alternative energy, materials research, and medicine - from fuel cells and batteries of the future to programmable materials and innovative approaches to drug design.
Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment.
A Spanish-US team of researchers has used a groundbreaking method to replicate the wings of butterflies and the colours of insects on a nanometric scale. The resulting technology has great potential to be used in a wide range of optical structures such as diffusers for solar panels or optical sensors.
The advances made in nanotechnology, particularly with respect to the biological and medical fields, are a testament to the herculean leaps made in nanotechnology in a short period of time, according to medical experts.
By analyzing data from the BNL Relativistic Heavy Ion Collider, the PHENIX collaboration at Brookhaven National Laboratory in Upton, USA, including scientists from the RIKEN BNL Research Center and the RIKEN Nishina Center for Accelerator-Based Science, has now ruled out gluons as the dominant contributor to proton spin.
Scientists at the University of Konstanz in Germany and the National Institute of Standards and Technology (NIST) in the United States have built the first optical frequency comb - a tool for precisely measuring different frequencies of visible light - that actually looks like a comb.
Using precision techniques for making superconducting thin films layer-by-layer, physicists at the Brookhaven National Laboratory have identified a single layer responsible for one such material's ability to become superconducting, i.e., carry electrical current with no energy loss.
A team of investigators from the University of Toronto have used nanomaterials to develop an inexpensive microchip sensitive enough to quickly determine the type and severity of a patient's cancer so that the disease can be detected earlier for more effective treatment.
Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. One approach showing promise in overcoming multidrug resistance in tumors is to combine two different anticancer agents in one nanoscale construct, providing a one-two punch that can prove lethal to such resistant cells.